Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Autoimmune Disorders

Free Subscription 08.12.2025 1 Ann Neurol 4 BMC Neurol 4 Brain 4 Diabetes Res Clin Pract 4 Intern Med 2 J Autoimmun 1 J Clin Endocrinol Metab 7 J Neuroimmunol 3 J Neurol 2 J Pediatr Endocrinol Metab 2 J Rheumatol 1 Kidney Int 2 Lancet 7 Mult Scler 2 Nat Rev Neurol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. CHEN J, Su C, Feng L, Wang H, et al
   Effects of Thymectomy in Late-Onset Myasthenia Gravis: A Multi-Center Longitudinal Retrospective Study.
   Ann Neurol. 2025 Nov 24. doi: 10.1002/ana.78093.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. ZHANG Y, Liu H, Li Z, Zhou M, et al
   A real-world retrospective study to assess the effectiveness and safety profile of siponimod in Chinese patients with relapsing forms of multiple sclerosis.
   BMC Neurol. 2025;25:491.
   PubMed         Abstract available
   
   
3. KAZEMI PAKDEL F, Kazemi Pakdel A, Zarei H, Brian A, et al
   Combined training improves functional capacity, fatigue, and quality of life in individuals with multiple sclerosis: a systematic review and meta-analysis.
   BMC Neurol. 2025 Dec 3. doi: 10.1186/s12883-025-04548.
   PubMed         Abstract available
   
   
4. NAWAZ A, Bakhtiyar A, Khan MI, Siddiqui E, et al
   Comparative efficacy and safety of ocrelizumab in relapsing-remitting and primary progressive multiple sclerosis: A systematic review and meta-analysis.
   BMC Neurol. 2025 Nov 21. doi: 10.1186/s12883-025-04519.
   PubMed         Abstract available
   
   
5. PENG Y, Hu L, Wang Y, Liang Y, et al
   Predictors of return to work status among patients with autoimmune encephalitis at one year post-discharge: a prospective observational study.
   BMC Neurol. 2025 Nov 21. doi: 10.1186/s12883-025-04527.
   PubMed         Abstract available
   
   

   
   Brain

6. WILLARD C, Puglisi L, Ravi D, Dmitrieva M, et al
   Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types.
   Brain. 2025 Dec 2:awaf331. doi: 10.1093.
   PubMed         Abstract available
   
   
7. LIN TY, McCormack B, Bacchetti A, Inserra M, et al
   Combining inter-eye differences enhances detection of optic nerve involvement in multiple sclerosis.
   Brain. 2025 Nov 26:awaf450. doi: 10.1093.
   PubMed         Abstract available
   
   
8. SUMOWSKI JF, Levy S, Katz Sand I, Brandstadter R, et al
   Cognition in multiple sclerosis within the modern diagnostic and treatment era.
   Brain. 2025 Nov 26:awaf446. doi: 10.1093.
   PubMed         Abstract available
   
   
9. BIGOTTE M, Groh AMR, Afanasiev E, Wong V, et al
   Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.
   Brain. 2025 Nov 24:awaf440. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

10. DOVC K, Tuomaala A, Kuusela S, Shetty A, et al
    Consistent efficacy and safety of automated insulin delivery in children aged 2-6 years: results from the LENNY trial continuation phase.
    Diabetes Res Clin Pract. 2025;230:112934.
    PubMed         Abstract available
    
    
11. BENNETT HO, Bogumil D, Kysh L, van den Brandt P, et al
    Systematic review and meta-analysis corrected for history of smoking tobacco identifies type 1 diabetes as a possible risk factor for bladder cancer.
    Diabetes Res Clin Pract. 2025 Oct 29:112976. doi: 10.1016/j.diabres.2025.112976.
    PubMed         Abstract available
    
    
12. HONDA T, Henry T, VanDerslice J, Porucznik CA, et al
    Ambient particulate air pollution is associated with higher risk of microvascular complications and diabetic ketoacidosis among persons with type 1 diabetes mellitus in an observational survival study.
    Diabetes Res Clin Pract. 2025;230:112983.
    PubMed         Abstract available
    
    
13. HAAPANEN MJ, Jansson Sigfrids F, Ylinen A, Satuli-Autere S, et al
    Frailty outperforms conventional risk factors for predicting complications and death in type 1 diabetes.
    Diabetes Res Clin Pract. 2025;230:112984.
    PubMed         Abstract available
    
    

    
    Intern Med

14. NAGAO N, Funakubo Asanuma Y, Kitahara T, Matsuda H, et al
    A Retrospective Observational Study of Otitis Media with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.
    Intern Med. 2025;64:3334-3342.
    PubMed         Abstract available
    
    
15. MIZUTA Y, Fujita S, Yamada M, Ikeda M, et al
    Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge.
    Intern Med. 2025;64:3447-3452.
    PubMed         Abstract available
    
    
16. KAWASAKI T, Tsuzaki K, Uehara N, Wada S, et al
    Generalized Myasthenia Gravis with Anti-acetylcholine Receptor Antibodies during the Clinical Course of Spinal and Bulbar Muscular Atrophy: A Case Report.
    Intern Med. 2025 Dec 4. doi: 10.2169/internalmedicine.6236.
    PubMed         Abstract available
    
    
17. SATO S, Uwatoko H, Yaguchi H, Yamada M, et al
    A Retrospective Study of 116 Multiple Sclerosis Patients with Dimethyl Fumarate Treatment in a Single Institution in Japan.
    Intern Med. 2025 Nov 27. doi: 10.2169/internalmedicine.6217.
    PubMed         Abstract available
    
    

    
    J Autoimmun

18. FRITZLER MJ, Muro Y, Klotz W, Herold M, et al
    Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern.
    J Autoimmun. 2025;158:103503.
    PubMed         Abstract available
    
    
19. SAXENA D, Walter K, Amona E, Kong M, et al
    Prior murine neurotropic coronavirus infection ameliorates experimental autoimmune encephalitis.
    J Autoimmun. 2025;158:103504.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

20. MIRJALILI SR, Razmpoosh E, Eshraghi R, Ashoori M, et al
    Comparative Efficacy of Radioiodine Therapy With Adjunctive Thionamides vs Either Treatment Alone in the Management of Graves Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2025 Dec 1:dgaf580. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

21. JIA R, Yao X, Liu Q, Wang X, et al
    Identification of the core genes KLRB1 and RETN as potential shared diagnostic markers for major depressive disorder and systemic lupus erythematosus through bioinformatics and machine learning methodologies.
    J Neuroimmunol. 2025;410:578811.
    PubMed         Abstract available
    
    
22. VINCIGUERRA C, Montalbano G, Virzi V, Rini N, et al
    Psychopathology in myasthenia gravis: Results from a multicenter Italian study.
    J Neuroimmunol. 2025;410:578807.
    PubMed         Abstract available
    
    
23. ZHANG Y, Lv X, Wang Q, Ma X, et al
    Prior dexamethasone exposure attenuates the therapeutic efficacy of mouse bone marrow-derived mesenchymal stem cells in experimental autoimmune encephalomyelitis by fostering a hostile immunological microenvironment.
    J Neuroimmunol. 2025;410:578814.
    PubMed         Abstract available
    
    
24. MESSINA C
    IL-17 and IL-22 in Guillain-Barre syndrome: Untangling disease-specific signals from confounding factors.
    J Neuroimmunol. 2025;410:578820.
    PubMed        
    
    
25. MIYAZAKI Y, Yokote H, Fujimori J, Sakurai K, et al
    Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study.
    J Neuroimmunol. 2025;410:578819.
    PubMed         Abstract available
    
    
26. FOMINYKH V, Kovaleva I, Aksenova E, Kondrasheva E, et al
    Autoimmune encephalitis in first episode psychosis: Prospective non-interventional longitudinal study in tertiary psychiatric center.
    J Neuroimmunol. 2025;410:578815.
    PubMed         Abstract available
    
    
27. HAYASHI M
    Diversity of childhood-onset myasthenia gravis: pathophysiology and treatment.
    J Neuroimmunol. 2025;411:578803.
    PubMed         Abstract available
    
    

    
    J Neurol

28. ELLINGHAUS CA, Rohling HM, Dorsch EM, Sperber PS, et al
    Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosis.
    J Neurol. 2025;273:4.
    PubMed         Abstract available
    
    
29. HEDSTROM AK, Olsson T, Alfredsson L
    Determinants and prognostic value of onset symptoms in multiple sclerosis.
    J Neurol. 2025;273:2.
    PubMed         Abstract available
    
    
30. WANG Z, Li S, Liu J, Li Y, et al
    Nomograms integrating cortical morphometric metrics with 3D multi-parametric MRI radiomics for predicting disability progression and cognitive worsening in relapsing-remitting multiple sclerosis: a multi-center validation study.
    J Neurol. 2025;272:792.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

31. PEMBERTON J, Leal C, Kohli A, Drummond L, et al
    The differential impact of automated insulin delivery systems on body mass index in children with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2025;38:1258-1269.
    PubMed         Abstract available
    
    
32. ONISHI Y, Higuchi S, Iwata K, Watanabe Y, et al
    Transient worsening of thyrotoxic myopathy following methimazole and metoprolol initiation in a 12-year-old girl: a case report and literature review.
    J Pediatr Endocrinol Metab. 2025;38:1367-1373.
    PubMed         Abstract available
    
    

    
    J Rheumatol

33. DAVIS NA, Wang J, Wang X, Getachew LS, et al
    Investigating factors associated with respiratory syncytial virus vaccination and breakthrough infection among patients with systemic autoimmune rheumatic diseases.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0934. doi: 10.3899/jrheum.2025-0934.
    PubMed         Abstract available
    
    
34. ALY S, Parastandehchehr G, Bernatsky S, Vinet E, et al
    A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0757. doi: 10.3899/jrheum.2025-0757.
    PubMed         Abstract available
    
    

    
    Kidney Int

35. CHRYSOSTOMOU C, Faustini F, Segelmark M, Carrero JJ, et al
    A national cohort study examined the risk of severe infection and infection-related mortality in patients with chronic kidney disease with lupus nephritis in comparison to other chronic kidney disease etiologies.
    Kidney Int. 2025 Nov 21:S0085-2538(25)00883-X. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Lancet

36. ZIEGLER AG, Achenbach P, Weiss A, Berner R, et al
    Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
    Lancet. 2025 Nov 11:S0140-6736(25)01726-X. doi: 10.1016/S0140-6736(25)01726.
    PubMed         Abstract available
    
    
37. FISHER BA
    Nipocalimab for Sjogren's disease-the importance of autoantibodies.
    Lancet. 2025;406:2397-2398.
    PubMed        
    
    

    
    Mult Scler

38. KIM TB, Lee JY, Brinker A, Lee PR, et al
    Anaphylaxis and glatiramer acetate.
    Mult Scler. 2025;31:1664-1671.
    PubMed         Abstract available
    
    
39. BONAN L, Camilli F, Bombardi M, Leoni C, et al
    The cascade sign in aquaporin-4-IgG positive (AQP4-IgG+) NMOSD.
    Mult Scler. 2025;31:1679-1682.
    PubMed         Abstract available
    
    
40. HARROUD A, Antel JP
    Neuroimmune interactions: How past lessons can inform the present and future of MS care.
    Mult Scler. 2025;31:1611-1618.
    PubMed         Abstract available
    
    
41. HOOSHMAND SJ, Vorasoot N, Li X, Chen JJ, et al
    Application of the ADEM definition to cerebral attacks of MOG antibody-associated disease.
    Mult Scler. 2025;31:1629-1640.
    PubMed         Abstract available
    
    
42. DAUBY S, Dive D, Hansen I, Lommers E, et al
    Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosis.
    Mult Scler. 2025 Nov 30:13524585251390859. doi: 10.1177/13524585251390859.
    PubMed         Abstract available
    
    
43. BARBUTI E, Pozzilli C, Borriello G, Petracca M, et al
    Addressing autoimmune comorbidities in multiple sclerosis: A case report of ulcerative colitis remission in a patient treated with cladribine tablets.
    Mult Scler. 2025 Nov 30:13524585251396258. doi: 10.1177/13524585251396258.
    PubMed         Abstract available
    
    
44. LU J, Brownlee WJ
    Cladribine: A useful treatment option in multiple sclerosis patients with autoimmune comorbidities.
    Mult Scler. 2025 Nov 30:13524585251396293. doi: 10.1177/13524585251396293.
    PubMed        
    
    

    
    Nat Rev Neurol

45. DOBSON R, Kreft KL, Jacobs BM, Brown JWL, et al
    Towards primary prevention of multiple sclerosis.
    Nat Rev Neurol. 2025 Nov 27. doi: 10.1038/s41582-025-01164.
    PubMed         Abstract available
    
    
46. WOOD H, Rivera V
    Addressing multiple sclerosis disparities in Latin American and other populations.
    Nat Rev Neurol. 2025 Nov 25. doi: 10.1038/s41582-025-01170.
    PubMed        
    
    

    
    PLoS One

47. SAMA SR, Gore R, Bauer AZ, Garber L, et al
    Autoimmune diseases as pre-existing conditions and sequelae of post COVID-19 condition in a Massachusetts community based observational study of COVID-19 patients.
    PLoS One. 2025;20:e0337848.
    PubMed         Abstract available
    
    
48. BEVERLY EA, Miller S, Schmidtgesling L, Whistler K, et al
    How coping styles moderate the relationship between diabetes distress and self-care in adults with diabetes in Appalachian Ohio: A cross-sectional survey study.
    PLoS One. 2025;20:e0337481.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.